Immunoexpression of vascular endothelial growth factor in periapical granulomas, radicular cysts, and residual radicular cysts by Nonaka, Cassiano Francisco Weege et al.
Vol. 106 No. 6 December 2008
ENDODONTOLOGY Editor: Larz S. W. SpångbergImmunoexpression of vascular endothelial growth factor in
periapical granulomas, radicular cysts, and residual
radicular cysts
Cassiano Francisco Weege Nonaka, DDS, MSc,a Alexandre Pinto Maia, DDS, MSc,a
George João Ferreira do Nascimento, DDS, MSc,a Roseana de Almeida Freitas, DDS, PhD,b
Lélia Batista de Souza, DDS, PhD,b and Hébel Cavalcanti Galvão, DDS, PhD,b Natal, Brazil
ORAL PATHOLOGY DEPARTMENT, FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE
Objective. Our aim was to assess and compare the immunoexpression of vascular endothelial growth factor (VEGF) in
periapical granulomas (PGs), radicular cysts (RCs), and residual radicular cysts (RRCs), relating it to the angiogenic
index and the intensity of the inflammatory infiltrate.
Study design. Twenty PGs, 20 RCs, and 10 RRCs were evaluated by immunohistochemistry using anti-VEGF antibody.
Angiogenic index was determined by microvessel count (MVC) using anti–von Willebrand factor antibody.
Results. The PGs and RCs showed higher expression of VEGF than the RRCs. Lesions presenting few inflammatory
infiltrate revealed the lowest immunoexpression of VEGF (P  .05). Irrespective of the intensity of the inflammatory
infiltrate, most of the RCs and RRCs showed moderate to strong epithelial expression of VEGF. Lesions showing dense
inflammatory infiltrate presented higher MVC indices (P  .05). VEGF expression and MVC did not reveal a significant
correlation (P  .05).
Conclusions. VEGF is present in periapical inflammatory lesions but at a lower level in RRCs. The expression of this
proangiogenic factor is closely related to the intensity of the inflammatory infiltrate in these lesions. (Oral Surg Oral
Med Oral Pathol Oral Radiol Endod 2008;106:896-902)Periapical lesions, which include periapical granulomas
(PGs) and radicular cysts (RCs), occur as a result of the
immunologic response to continuous antigenic stimu-
lation from root canals.1,2 Persistence of the inflamma-
tion is associated with resorption of adjacent bone,
which is replaced by a granulation tissue to form a PG.2
As a consequence of inflammatory and immunologic
responses, the epithelial remnants of Malassez are stim-
ulated to proliferate, which may result in the develop-
ment of an RC.3 By definition, residual radicular cysts
(RRCs) represent RCs that are inadvertently left behind
after the extraction of the involved tooth.4,5
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896Vascular endothelial growth factor (VEGF) is a po-
tent proangiogenic cytokine secreted by many cell
types which presents several pivotal functions in phys-
iologic and pathologic angiogenesis.6-8 VEGF acts on
the vasculature by inducing the proliferation, differen-
tiation, and migration of vascular endothelial cells.8-10
In addition, VEGF can induce microvascular perme-
ability, leading to extravasation of plasma proteins,
fluid accumulation, and edema.7,9,10 Therefore, VEGF
has been implicated as an important factor in granula-
tion tissue development.8,11,12
Recent studies suggest a role for VEGF in enlarge-
ment of cysts. It has been speculated that the presence
of VEGF in cystic lesions is capable of increasing
vascular permeability, leading to accumulation of cys-
tic fluid.13-17 Leonardi et al.18 proposed a similar func-
tion for VEGF in periapical lesions. According to those
authors, the expression of VEGF in PGs and RCs has
bioactivity to increase vascular permeability, being at
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matory cells and cyst fluid.
The importance of vascular networks in the devel-
opment and maintenance of tissues have been demon-
strated in many physiologic and pathologic processes,
such as embryogenesis, wound healing, inflammation,
and tumor progression.6-8,10,11 Angiogenesis is the pro-
cess by which new blood vessels are produced by
sprouting from preexisting vasculature,7,8,10 and the
measurement of its role may be important for a better
understanding of the pathogenesis of neoproliferative
lesions.19 Although angiogenesis cannot be measured
directly, it can be assessed by quantification of the
vessels immunolabeled by specific antibodies against
endothelial cell epitopes, such as von Willebrand factor
(vWF).20 In this manner, it is possible to indirectly
establish the angiogenic activity of a tissue.20,21
To our knowledge, there are no studies analyzing the
expression of VEGF in PGs, RCs, and RRCs. There-
fore, the aim of the present study was to assess and
compare the immunoexpression of VEGF in these le-
sions, relating it to the angiogenic index and the inten-
sity of the inflammatory infiltrate.
MATERIALS AND METHODS
Fifty tissue specimens, 20 PGs, 20 RCs and 10
RRCs, archived in the files of the Oral Pathology De-
partment of the Federal University of Rio Grande do
Norte (UFRN) were randomly selected for this study.
All PGs and RCs were obtained from teeth without
endodontic treatment. Only PGs without odontogenic
epithelium were selected. Moreover, all RCs and RRCs
presented unequivocal cystic cavity lined by odonto-
genic epithelium. The cases were not matched for age,
gender, or anatomic location. Serial sections, 3-5 m
thick, were taken from tissue blocks and processed for
morphologic and immunohistochemical studies. The
study was approved by the Research Ethics Committee
of the UFRN, Natal, Brazil.
Morphologic analysis
For the morphologic analysis, tissue sections were
stained with hematoxylin and eosin. The intensity of
the inflammatory infiltrate was evaluated according to
the method proposed by Tsai et al.4 Briefly, each spec-
Table I. Specificity, dilution, antigen retrieval, and inc
Ab clone Specificity Dilution
C-1* VEGF 1:400
F8/86† vWF 1:50
*Santa Cruz Biotechnology.
†Dako Cytomation.imen was graded at 200 magnification as: grade I,inflammatory cells less than one-third per field; grade
II, inflammatory cells between one-third and two-thirds
per field; and grade III, inflammatory cells more than
two-thirds per field. Grading of each specimen was
recorded on the average inflammatory condition in 3
consecutive microscopic fields, starting from the inner
portion of the specimen and proceeding deeper into
connective tissue. Epithelial thickness was defined as
atrophic (2-10 cell layers) or hyperplastic (10 cell
layers), according to Moreira et al.22
Immunohistochemical methods
For the immunohistochemical study, tissue sections
were deparaffinized and immersed in methanol with
0.3% hydrogen peroxide to block endogenous peroxi-
dase activity. The tissue sections were then washed in
phosphate-buffered saline (PBS). The antigen retrieval,
antibody dilution, and clone type for VEGF and vWF
are shown in Table I. After treatment with normal
serum, the tissue sections were incubated in a moist
chamber with primary antibodies. The tissue sections
were then washed twice in PBS and treated with strep-
toavidin-biotin-peroxidase complex (SABC; Dako,
Glostrup, Denmark) at room temperature to bind the
primary antibodies. Peroxidase activity was visualized
by immersing tissue sections in diaminobenzidine
(D5637; Sigma Chemical, St. Louis, MO), resulting in
a brown reaction product. Finally, tissue sections were
counterstained with Mayer hematoxylin and cover-
slipped. Positive control samples for VEGF and vWF
were sections of normal human kidney. As negative
control, samples were treated as above, except that the
primary antibody was replaced by a solution of bovine
serum albumin in PBS.
Immunostaining assessment and statistical
analysis
After the immunohistochemical treatment, the tissue
sections were examined by light microscopy. Immuno-
histochemical expression of VEGF was evaluated both
in the connective tissue of PGs, RCs, and RRCs and in
the epithelial lining of RCs and RRCs. In the connec-
tive tissue, a quantitative assessment of the immunopo-
sitive cells, irrespective of the color intensity, was
performed according to the method proposed by Freitas
n of the antibody (Ab) clones
Antigen retrieval Incubation
rypsin pH 7.9, oven 37°C, 60 min Overnight (18 h)
itrate pH 6.0, steamer, 30 min 60 minubatio
T
Cet al.20 Tissue sections were examined by light micros-
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the largest number of immunostained cells. Using
400 magnification, the counting of the immunoposi-
tive cells was performed in each one of these fields.
The immunoexpression of VEGF in the epithelial
lining of RCs and RRCs was semiquantitatively eval-
uated, using 100 magnification. Performing an adap-
tation of the method proposed by Leonardi et al.,18 the
epithelial immunoexpression of VEGF was classified
according to the following parameters: no staining in
10% of cells; weak, staining in 11%-25% of cells;
moderate, staining in 26%-75% of cells; strong, stain-
ing in 76% of cells.
Angiogenic index in PGs, RCs, and RRCs was de-
termined based on the number of vessels immunoreac-
tive to anti-vWF antibody. Adopting the methodology
proposed by Freitas et al.,20 a microvessel count
(MVC) was performed. Tissue sections were examined
by light microscope at 40 magnification, and 5 areas
showing the highest vascularization were identified
subjectively. In these areas, vessels were counted at
200 magnification.
The results obtained were submitted to statistical
analysis. Computations were made using the Statistical
Package for the Social Sciences (SPSS 13.0). To ana-
lyze the immunohistochemical expression of VEGF in
the epithelial lining of RCs and RRCs, Fisher exact test
was performed. To compare the number of cells immu-
noreactive for VEGF in the connective tissue of PGs,
RCs, and RRCs, the nonparametric Kruskal-Wallis test
was performed. The analysis of the number of vessels
in PGs, RCs, and RRCs was evaluated by the Kruskal-
Wallis and Mann-Whitney nonparametric tests. Finally,
Spearman correlation test was performed to verify pos-
sible correlations between the number of immunoposi-
tive cells for VEGF and the number of MVC. For all
tests, significance level was set at .05 (P  .05).
RESULTS
Morphologic analysis
Analysis of the inflammatory infiltrate in PGs re-
vealed 19 cases (95%) with inflammatory infiltrate
grade III and only 1 specimen (5%) with inflammatory
infiltrate grade II. In RCs, 14 cases (70%) showed
inflammatory infiltrate grade III, 5 cases (25%) inflam-
matory infiltrate grade II, and only 1 case (5%) inflam-
matory infiltrate grade I. In the group of RRCs, 4 cases
(40%) showed inflammatory infiltrate grade I, 3 cases
(30%) inflammatory infiltrate grade II, and 3 cases
(30%) inflammatory infiltrate grade III.
Morphologic analysis of the epithelial thickness in
RCs revealed the presence of a hyperplastic epithelium
in 14 cases (70%) and an atrophic epithelium in only 6
cases (30%). In RRCs, 6 cases (60%) presented anatrophic epithelium and 4 cases (40%) showed a hy-
perplastic epithelium.
Considering all cystic lesions with hyperplastic epi-
thelium (n  18), 13 cases (72.2%) presented inflam-
matory infiltrate grade III, 3 cases (16.7%) inflamma-
tory infiltrate grade II, and 2 cases (11.1%)
inflammatory infiltrate grade I. Considering cystic le-
sions with atrophic epithelium (n  12), 5 cases
(41.7%) presented inflammatory infiltrate grade II, 4
cases (33.3%) inflammatory infiltrate grade III, and 3
cases (25%) inflammatory infiltrate grade I.
Immunohistochemical analysis
The mean number of cells immunostained with anti-
VEGF antibody was 564.90 (range 254-916) and
565.05 (range 214-792) in PGs and RCs, respectively.
In RRCs, the mean number of immunopositive cells
was 443.90 (range 222-660). Grouping all lesions ac-
cording to the intensity of the inflammatory infiltrate,
the mean number of immunopositive cells for VEGF
was 390.40 (range 222-548) in lesions with inflamma-
tory infiltrate grade I (n  5) (Fig. 1). In lesions with
inflammatory infiltrate grade II (n  9), the mean
number of immunoreactive cells was 428.22 (range
214-792). In lesions with inflammatory infiltrate grade
III (n  36), the mean number of immunopositive cells
was 589.78 (range 314-916) (Fig. 2).
The analysis of the immunoreactivity of VEGF in the
epithelium of RCs revealed weak expression in 2 cases
(10%), moderate expression in 7 cases (35%), and
strong expression in 11 cases (55%). Only moderate
and strong immunoreactivities for VEGF were ob-
served in the epithelium of RRCs. Three cases (30%)
presented moderate expression and 7 cases (70%)
Fig. 1. Immunoexpression of VEGF in specimen of residual
radicular cyst presenting inflammatory infiltrate grade I
(SABC method, original magnification 400).strong expression.
OOOOE
Volume 106, Number 6 Nonaka et al. 899Grouping RCs and RRCs according to epithelium
thickness, in lesions with hyperplastic epithelium (n 
18) 8 cases (44.4%) presented moderate epithelial ex-
pression of VEGF and 10 cases (55.6%) strong immu-
noreactivity (Fig. 3). In lesions with atrophic epithe-
lium (n  12), 2 cases (16.7%) showed weak epithelial
expression of VEGF, 2 cases (16.7%) moderate expres-
sion, and 8 cases (66.6%) strong expression (Fig. 4).
The mean number of blood vessels determined by
MVC in PGs and RCs was 210.45 (range 124-279) and
250.85 (range 159-350), respectively (Fig. 5). In RRCs,
the mean number of blood vessels was 217.00 (range
114-366). Grouping all lesions according to the inten-
sity of the inflammatory infiltrate, the mean number of
blood vessels was 192.20 (range 152-252) in lesions
Fig. 2. Immunoexpression of VEGF in specimen of periapi-
cal granuloma presenting inflammatory infiltrate grade III
(SABC method, original magnification 400).
Fig. 3. Strong epithelial expression of VEGF in specimen of
residual radicular cyst with hyperplastic epithelial lining
(SABC method, original magnification 400).with inflammatory infiltrate grade I (n  5). In lesionswith inflammatory infiltrate grade II (n  9), the mean
number of blood vessels was 202.89 (range 114-350).
Lesions with inflammatory infiltrate grade III (n  36)
showed a mean number of blood vessels of 239.14
(range 124-409).
Statistical analysis
Analysis of the number of immunopositive cells for
VEGF in the connective tissue of PGs, RCs, and RRCs,
performed by nonparametric Kruskal-Wallis test,
showed no statistically significant difference (P  .05)
(Table II). Nevertheless, comparison of the number of
immunopositive cells for VEGF according to the inten-
sity of the inflammatory infiltrate revealed a statistically
significant difference between groups (P  .05) (Table
Fig. 4. Strong epithelial expression of VEGF in specimen of
radicular cyst with atrophic epithelial lining (SABC method,
original magnification 400).
Fig. 5. Vessels immunoreactive to anti-vWF antibody in
specimen of residual radicular cyst (SABC method, original
magnification 100).III).
OOOOE
900 Nonaka et al. December 2008Fisher exact test was performed to compare the ep-
ithelial expression of VEGF in RCs and RRCs. No
differences were observed between groups (P  .05).
In addition, comparison of the immunoexpression of
VEGF according to the epithelial thickness revealed no
statistically significant differences between lesions with
atrophic epithelium and lesions with hyperplastic epi-
thelium (P  .05).
Regarding the number of blood vessels of PGs, RCs,
and RRCs, nonparametric Kruskal-Wallis test revealed
no difference between groups (P  .05). In addition,
comparison of the number of blood vessels according to
the intensity of the inflammatory infiltrate did not re-
veal significant differences (P  .05). Nevertheless,
when lesions showing inflammatory infiltrate grades I
and II were grouped and compared with those present-
ing inflammatory infiltrate grade III, nonparametric
Mann-Whitney test revealed a significant difference (P
 .05) (Table IV).
Spearman correlation test disclosed no significant
correlation between the number of immunopositive
cells for VEGF and the angiogenic index (P  0.118).
DISCUSSION
Despite intense investigation,2,3,22-24 the molecular
mechanisms involved in the formation of granulation
tissue and enlargement of jaw cysts have not been fully
clarified. Recent studies suggest an important role for
VEGF in the pathogenesis of PGs and RCs.18,19 A
dimeric glycoprotein with a selective mitogenic effect
on vascular endothelial cells, VEGF is an extremely
potent and specific angiogenic factor.6-10 Moreover,
VEGF is capable of inducing microvascular permeabil-
ity with a potency some 50,000 times that of hista-
mine, leading to extravasation of plasma proteins and
a predictable sequence of proangiogenic stromal
changes.6,18 Therefore, VEGF has been implicated as
an important factor in granulation tissue develop-
ment7,8,11,12 and cyst enlargement.13-17
In the present study, we evaluated the expression of
Table II. Parameters used for the calculation of the
Kruskal-Wallis (KW) test for the evaluation of the
number of immunopositive cells for VEGF in PGs,
RCs, and RRCs
Lesion n Median Q25-Q75
Mean of
the ranks KW
P
value
PG 20 586.00 406.25–690.25 27.55 3,315 .191
RC 20 590.50 505.75–688.75 27.20
RRC 10 460.00 256.00–618.50 18.00
PG, Periapical granuloma; RC, radicular cyst; RRC, residual radicular
cyst; Q, quartile.VEGF in PGs, RCs, and RRCs. The results revealedthat VEGF is expressed in the connective tissue of all of
these lesions and in the epithelial lining of RCs and
RRCs, corroborating earlier studies.18,19 According to
Leonardi et al.,18 the expression of VEGF in periapical
lesions has bioactivity to increase vascular permeabil-
ity, being partially involved in the accumulation of
inflammatory cells and cyst fluid. Therefore, in accor-
dance with the biologic functions described for VEGF,
such as inducing microvascular permeability and being
a potent mitogenic factor for endothelial cells,6-8 the
present findings suggest the participation of this proan-
giogenic factor in the development and enlargement of
PGs, RCs, and RRCs.
Despite the absence of statistical significance (P 
.05), PGs and RCs presented a higher mean number of
immunopositive cells for VEGF compared with RRCs.
PGs and RCs present a constant source of stimulation
by bacterial toxins released from the infected root canal
which are not present in RRCs.3 In addition, Muglali et
al.3 verified higher levels of interleukin-1, monocyte
chemotactic protein 1, and regulated upon activation
normal T-cell expressed and secreted (RANTES) in
cystic fluids of RCs compared with cystic fluids of
RRCs. Interleukin-1 is a cytokine that has been
involved in up-regulation of the expression of
VEGF.7,25,26 Monocyte chemotactic protein 1 and
RANTES are important chemokines that regulate mac-
rophage infiltration in tissues.3,27 Besides their func-
tions as antigen-presenting cells and phagocytes during
wound repair, macrophages present a proangiogenic
potential,28 suggesting a functional contribution of
these cells in wound angiogenesis.27,29 Therefore, the
low mean number of immunopositive cells for VEGF in
RRCs observed in the present study might be related to
a decreased level of cytokines in these lesions, as a
consequence of the reduction of the inflammatory stim-
uli.
Leonardi et al.18 verified marked differences in the
expression of VEGF between PGs and RCs. In their
study, many inflammatory cells in PGs were immu-
nopositive for VEGF, but there was a progressive de-
crease in the number of such immunolabeled cells to
almost none in RCs. Therefore, Leonardi et al.18 sug-
gested that inflammatory cells and fibroblasts would be
responsible for synthesis of VEGF in the early phases
of periapical lesion development and epithelial cells in
the later ones.
In the present study, we could not verify such pro-
gressive decrease in the immunoexpression of VEGF.
The differences between our results and those reported
by Leonardi et al.18 might be due to the small sample of
RCs used in their research. Moreover, Leonardi et al.18
did not report if the intensity of the inflammatory in-
filtrate was evaluated in their study. In the present
.75–259
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revealed a lower number of immunopositive cells for
VEGF than lesions showing inflammatory infiltrate
grade III (P  .05). Similarly, Graziani et al.19 verified
a positive correlation between the intensity of the in-
flammatory infiltrate and the expression of VEGF in
periapical lesions.
Most of the RCs and RRCs evaluated in the present
study presented a moderate to strong epithelial expression
of VEGF, irrespective of the intensity of the inflammatory
infiltrate or the thickness of the epithelial lining. The
epithelial expression of VEGF in RCs and RRCs might
constitute an additional mechanism for the enlargement of
these lesions, maintaining the stimulus for angiogenesis
and vascular permeability, a role also proposed by Leo-
nardi et al.18 Results from studies of the expression of
VEGF in brain tumor cysts13,15,17 and cyst fluid of thyroid
nodules14,16 also corroborate this suggestion. According
to Vaquero et al.,15 VEGF might enhance accumulation of
cyst fluid, together with an increase in oxygen supply
boosting the development of the cyst.
The epithelium status of the RCs (hyperplastic or atro-
phic) has been suggested as a reliable histologic parameter
of biologic activity and/or inactivity of cystic growth.22,30
On quiescent lesions (atrophic epithelium), despite the
presence of antigens and enzymes able to induce immu-
nologic responses, epithelium proliferation, and bone re-
sorption, cyst enlargement does not occur.22 In such
phases, immunosuppressor effectors22 or apoptotic
events31 may operate to regulate cyst enlargement. De-
spite those reports, the present results revealed that most
of the RCs and RRCs with atrophic epithelial lining
present strong epithelial expression of VEGF. These find-
ings might suggest the existence of a potential for expan-
sion in cystic lesions with atrophic epithelium.
The present results showed that lesions with a dense
Table III. Parameters used for the calculation of the K
immunopositive cells for vascular endothelial growth f
Inflammatory infiltrate n Median
Grade I 5 373.00 242
Grade II 9 298.00 246
Grade III 36 611.00 542
Q, Quartile.
Table IV. Parameters used for the calculation of the Ma
immunostained by anti–von Willebrand factor antibody
Inflammatory infiltrate n Median
Grade I/II 14 191.00 155
Grade III 36 232.50 198
Q, Quartile.inflammatory infiltrate (grade III) present both a highnumber of immunopostive cells for VEGF (P  .05)
and a high MVC (P  .05). These findings are in
accordance with other studies and highlight the impor-
tance of inflammatory cells, particularly neutrophils
and macrophages,27 on VEGF expression.19,32 In this
way, the low level of inflammation, probably due to
reduced antigenic stimulation,3 could be suggested as a
possible explanation for the low expression of VEGF,
and consequently low MVC, in RRCs.
Graziani et al.19 observed a positive correlation be-
tween the microvessel density and the expression of
VEGF. However, in our research, we could not find a
statistically significant correlation between MVC and
the number of immunopositive cells for VEGF. The
differences between our results and those reported by
Graziani et al.19 could be related to differences in the
methods selected for evaluation of the immunoreactiv-
ity. In addition, differing from our study, Graziani et
al.19 only evaluated RCs.
Despite the absence of statistical significance, RCs
presented a higher number of blood vessels compared
with PGs and RRCs. To our knowledge, there are no
previous studies in the literature that compared the
angiogenic index between PGs, RCs, and RRCs. The
low MVC observed in RRCs could be related to the
lower number of cells immunopositive for VEGF in
these lesions compared with RCs. However, PGs and
RCs showed a similar number of cells immunopositive
for VEGF. It could be hypothesized that the difference
in the number of blood vessels might be related to a
possible conversion of granulation tissue to a cyst. In
this way, it can be speculated that the limits of neovas-
cularization are reached and, as a result, the center of
the granuloma necroses. Additional studies are neces-
sary to clarify these observations.
In conclusion, our results revealed that VEGF is
l-Wallis (KW) test for the evaluation of the number of
according to the grade of the inflammatory infiltrate
Mean of the ranks KW P value
.50 11.70 9.736 .008
.00 17.56
.25 29.40
hitney U test for the evaluation of the number of vessels
rding to the grade of the inflammatory infiltrate.
Mean of the ranks U P value
.50 18.57 155.00 .036
.00 28.19ruska
actor
Q25-Q75
.00–547
.00–633
.75–690nn-W
acco
Q25-Q75
.00–231present in periapical inflammatory lesions, but at a
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902 Nonaka et al. December 2008lower level in RRCs. The expression of this pro-angio-
genic factor is closely related to the intensity of the
inflammatory infiltrate in these lesions. Further studies
need to be performed to clarify the role of VEGF and
other angiogenic factors in the pathogenesis of PGs,
RCs, and RRCs.
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